Hypoxic NSCLC cell derived-EVs promote PKM2-dependent glycolysis and subsequently produce metabolites to eliminate ROS, thereby inhibiting tumor apoptosis and promoting tumor growth (Wang et al., 2021). This evidence concerns the gene PKM and non-small cell lung carcinoma.